Navigation Links
NIDs Targets Immunizations To 22 Million Children In Bangladesh

Many governments have taken the National Polio Eradication Initiatives and now in an effort to eliminate polio re-emergence, 14th National //Immunization Days (NIDs) have planned to immunize 22 million children in Bangladesh under the age group of 0-5.

Government of Bangladesh will carry out the initiatives along with the support of UNICEF, World Health Organization (WHO), Rotary International and the U.S. Centers for Disease Control and Prevention (CDC). Since March, four polio NIDs have been held and so far around 97 percent of children under age five were been immunized.

While addressing a press conference Louis Georges Arsenault, a representative from UNICEF said: "We cannot but feel encouraged at the prompt and effective response mounted in order to counter the threat of polio re-emergence.” Dr. Duangvadee Sungkhobol, the country's WHO representative, added: “By working together, I am optimistic that we will be able to make Bangladesh polio-free once again,”

Professor Sufia Rahman, an advisor for the Ministry of Health and Family Welfare, Bangladesh inaugurated the 14th round of the NIDs on Friday. Moreover, the government has taken measures for total elimination of polio by continuing another 4 rounds of the NIDs in 2007 followed by two rounds every year starting from 2008.
SI
'"/>




Page: 1

Related medicine news :

1. Research Targets treatment for dementia and brain injuries
2. Cancer Treatments Fall Short Of Targets
3. India Targets Eliminating Leprosy
4. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
5. Health Targets To Treat Cancer Patients Unlikely To Be Met
6. "Super Drug" Targets Disease-Causing Gene
7. Queensland Government to Meet its Medical Targets
8. No Clear Evidence for Ultra-Low Cholesterol Targets?
9. Health Minister Stresses the Importance of Realistic Health Targets
10. Researchers Identify New Drug Targets for Cancer
11. VBI Provides Potential Targets to Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: